Aspira Women's Health Inc. (NASDAQ: AWH) Stock Competitors & Peer Comparison
See AWH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AWH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AWH | $0.08 | -15.90% | 2.5M | -0.09 | -$0.93 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.68% |
| TMO | $613.54 | +4.16% | 228B | 26.49 | $23.16 | +0.29% |
| DHR | $211.50 | +5.97% | 148.8B | 26.53 | $7.98 | +0.68% |
| NTRA | $325.07 | +3.47% | 44.6B | -236.13 | -$1.32 | N/A |
| IDXX | $562.20 | +1.60% | 44.3B | 39.54 | $14.22 | N/A |
| A | $155.41 | +4.70% | 43.9B | 26.75 | $5.81 | +0.65% |
| IQV | $249.28 | +3.85% | 41B | 20.56 | $12.13 | N/A |
| WAT | $415.84 | +3.64% | 31.1B | 30.39 | $13.68 | N/A |
| ILMN | $205.00 | +8.87% | 31B | 40.76 | $5.03 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
AWH vs DHR-PB Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, AWH's ROE is +1.62%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, AWH is less volatile compared to DHR-PB. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
AWH vs TMO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, TMO has a market cap of 228B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while TMO trades at $613.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas TMO's P/E ratio is 26.49. In terms of profitability, AWH's ROE is +1.62%, compared to TMO's ROE of +0.13%. Regarding short-term risk, AWH is less volatile compared to TMO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
AWH vs DHR Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DHR has a market cap of 148.8B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DHR trades at $211.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DHR's P/E ratio is 26.53. In terms of profitability, AWH's ROE is +1.62%, compared to DHR's ROE of +0.08%. Regarding short-term risk, AWH is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
AWH vs NTRA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NTRA has a market cap of 44.6B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NTRA trades at $325.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NTRA's P/E ratio is -236.13. In terms of profitability, AWH's ROE is +1.62%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, AWH is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NTRA's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
AWH vs IDXX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, IDXX has a market cap of 44.3B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while IDXX trades at $562.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas IDXX's P/E ratio is 39.54. In terms of profitability, AWH's ROE is +1.62%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, AWH is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
AWH vs A Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, A has a market cap of 43.9B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while A trades at $155.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas A's P/E ratio is 26.75. In terms of profitability, AWH's ROE is +1.62%, compared to A's ROE of +0.21%. Regarding short-term risk, AWH is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for AWH.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
AWH vs IQV Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, IQV has a market cap of 41B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while IQV trades at $249.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas IQV's P/E ratio is 20.56. In terms of profitability, AWH's ROE is +1.62%, compared to IQV's ROE of +0.22%. Regarding short-term risk, AWH is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for AWH.Check IQV's competition here
Waters Corporation (NYSE: WAT)
AWH vs WAT Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, WAT has a market cap of 31.1B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while WAT trades at $415.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas WAT's P/E ratio is 30.39. In terms of profitability, AWH's ROE is +1.62%, compared to WAT's ROE of +0.02%. Regarding short-term risk, AWH is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for AWH.Check WAT's competition here
Illumina, Inc. (NASDAQ: ILMN)
AWH vs ILMN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ILMN has a market cap of 31B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ILMN trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ILMN's P/E ratio is 40.76. In terms of profitability, AWH's ROE is +1.62%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, AWH is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
AWH vs MTD Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MTD has a market cap of 28.8B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MTD trades at $1,425.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MTD's P/E ratio is 32.71. In terms of profitability, AWH's ROE is +1.62%, compared to MTD's ROE of -12.00%. Regarding short-term risk, AWH is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MTD's competition here
Labcorp Holdings Inc. (NYSE: LH)
AWH vs LH Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, LH has a market cap of 27.1B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while LH trades at $330.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas LH's P/E ratio is 19.61. In terms of profitability, AWH's ROE is +1.62%, compared to LH's ROE of +0.12%. Regarding short-term risk, AWH is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for AWH.Check LH's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
AWH vs DGX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DGX has a market cap of 26.7B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DGX trades at $241.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DGX's P/E ratio is 23.84. In terms of profitability, AWH's ROE is +1.62%, compared to DGX's ROE of +0.14%. Regarding short-term risk, AWH is less volatile compared to DGX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DGX's competition here
Guardant Health, Inc. (NASDAQ: GH)
AWH vs GH Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, GH has a market cap of 21.9B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while GH trades at $163.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas GH's P/E ratio is -46.80. In terms of profitability, AWH's ROE is +1.62%, compared to GH's ROE of +2.11%. Regarding short-term risk, AWH is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for AWH.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
AWH vs EXAS Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas EXAS's P/E ratio is -95.37. In terms of profitability, AWH's ROE is +1.62%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, AWH is similarly volatile compared to EXAS. This indicates similar risk in terms of short-term price fluctuations for AWH.Check EXAS's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
AWH vs ILMNV Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ILMNV's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to ILMNV's ROE of N/A. Regarding short-term risk, AWH is similarly volatile compared to ILMNV. This indicates similar risk in terms of short-term price fluctuations for AWH.Check ILMNV's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
AWH vs MEDP Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MEDP has a market cap of 17B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MEDP trades at $608.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MEDP's P/E ratio is 35.65. In terms of profitability, AWH's ROE is +1.62%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, AWH is less volatile compared to MEDP. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MEDP's competition here
PerkinElmer, Inc. (NYSE: PKI)
AWH vs PKI Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PKI's P/E ratio is 41.45. In terms of profitability, AWH's ROE is +1.62%, compared to PKI's ROE of +0.03%. Regarding short-term risk, AWH is less volatile compared to PKI. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PKI's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
AWH vs CRL Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CRL has a market cap of 14B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CRL trades at $290.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CRL's P/E ratio is 29.29. In terms of profitability, AWH's ROE is +1.62%, compared to CRL's ROE of -0.08%. Regarding short-term risk, AWH is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CRL's competition here
Revvity, Inc. (NYSE: RVTY)
AWH vs RVTY Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, RVTY has a market cap of 13.3B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while RVTY trades at $119.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas RVTY's P/E ratio is 22.32. In terms of profitability, AWH's ROE is +1.62%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, AWH is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for AWH.Check RVTY's competition here
ICON Public Limited Company (NASDAQ: ICLR)
AWH vs ICLR Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ICLR has a market cap of 13.2B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ICLR trades at $172.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ICLR's P/E ratio is 14.07. In terms of profitability, AWH's ROE is +1.62%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, AWH is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
AWH vs QGEN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, QGEN has a market cap of 9.2B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while QGEN trades at $44.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas QGEN's P/E ratio is 18.39. In terms of profitability, AWH's ROE is +1.62%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, AWH is less volatile compared to QGEN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check QGEN's competition here
Twist Bioscience Corporation (NASDAQ: TWST)
AWH vs TWST Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, TWST has a market cap of 8.9B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while TWST trades at $142.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas TWST's P/E ratio is -64.14. In terms of profitability, AWH's ROE is +1.62%, compared to TWST's ROE of -0.30%. Regarding short-term risk, AWH is less volatile compared to TWST. This indicates lower risk in terms of short-term price fluctuations for AWH.Check TWST's competition here
RadNet, Inc. (NASDAQ: RDNT)
AWH vs RDNT Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, RDNT has a market cap of 5.9B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while RDNT trades at $75.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas RDNT's P/E ratio is 164.22. In terms of profitability, AWH's ROE is +1.62%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, AWH is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for AWH.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
AWH vs SHC Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, SHC has a market cap of 5.4B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while SHC trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas SHC's P/E ratio is 19.79. In terms of profitability, AWH's ROE is +1.62%, compared to SHC's ROE of +0.27%. Regarding short-term risk, AWH is less volatile compared to SHC. This indicates lower risk in terms of short-term price fluctuations for AWH.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
AWH vs SYNH Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas SYNH's P/E ratio is 61.40. In terms of profitability, AWH's ROE is +1.62%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, AWH is less volatile compared to SYNH. This indicates lower risk in terms of short-term price fluctuations for AWH.Check SYNH's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
AWH vs BLLN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BLLN has a market cap of 4.2B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BLLN trades at $91.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BLLN's P/E ratio is 130.96. In terms of profitability, AWH's ROE is +1.62%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, AWH is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BLLN's competition here
Veracyte, Inc. (NASDAQ: VCYT)
AWH vs VCYT Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, VCYT has a market cap of 3.4B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while VCYT trades at $42.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas VCYT's P/E ratio is 21.10. In terms of profitability, AWH's ROE is +1.62%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, AWH is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for AWH.Check VCYT's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
AWH vs OLK Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas OLK's P/E ratio is -96.59. In terms of profitability, AWH's ROE is +1.62%, compared to OLK's ROE of -0.07%. Regarding short-term risk, AWH is less volatile compared to OLK. This indicates lower risk in terms of short-term price fluctuations for AWH.Check OLK's competition here
Neogen Corporation (NASDAQ: NEOG)
AWH vs NEOG Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NEOG trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NEOG's P/E ratio is 43.39. In terms of profitability, AWH's ROE is +1.62%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, AWH is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NEOG's competition here
CareDx, Inc (NASDAQ: CDNA)
AWH vs CDNA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CDNA has a market cap of 2.4B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CDNA trades at $46.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CDNA's P/E ratio is 55.37. In terms of profitability, AWH's ROE is +1.62%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, AWH is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
AWH vs PSNL Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PSNL trades at $15.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PSNL's P/E ratio is -14.50. In terms of profitability, AWH's ROE is +1.62%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, AWH is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PSNL's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
AWH vs CSTL Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CSTL has a market cap of 987.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CSTL trades at $32.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CSTL's P/E ratio is -73.45. In terms of profitability, AWH's ROE is +1.62%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, AWH is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
AWH vs GRALV Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas GRALV's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to GRALV's ROE of N/A. Regarding short-term risk, AWH is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for AWH.Check GRALV's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
AWH vs FLGT Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, FLGT has a market cap of 560.6M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while FLGT trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas FLGT's P/E ratio is 1974.00. In terms of profitability, AWH's ROE is +1.62%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, AWH is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for AWH.Check FLGT's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
AWH vs NEO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NEO has a market cap of 428M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NEO trades at $16.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NEO's P/E ratio is 128.12. In terms of profitability, AWH's ROE is +1.62%, compared to NEO's ROE of -0.06%. Regarding short-term risk, AWH is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NEO's competition here
Global Cord Blood Corporation (NYSE: CO)
AWH vs CO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CO's P/E ratio is 5.06. In terms of profitability, AWH's ROE is +1.62%, compared to CO's ROE of +0.11%. Regarding short-term risk, AWH is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CO's competition here
Prenetics Global Limited (NASDAQ: PRE)
AWH vs PRE Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PRE has a market cap of 318.9M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PRE trades at $18.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PRE's P/E ratio is -9.11. In terms of profitability, AWH's ROE is +1.62%, compared to PRE's ROE of -0.49%. Regarding short-term risk, AWH is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PRE's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
AWH vs MYGN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MYGN has a market cap of 301.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MYGN trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MYGN's P/E ratio is -24.54. In terms of profitability, AWH's ROE is +1.62%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, AWH is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MYGN's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
AWH vs FLDM Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas FLDM's P/E ratio is -4.74. In terms of profitability, AWH's ROE is +1.62%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, AWH is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for AWH.Check FLDM's competition here
Prenetics Global Limited (NASDAQ: PRENW)
AWH vs PRENW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PRENW has a market cap of 260.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PRENW's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to PRENW's ROE of -0.49%. Regarding short-term risk, AWH is less volatile compared to PRENW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PRENW's competition here
Trinity Biotech plc (NASDAQ: TRIB)
AWH vs TRIB Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, TRIB has a market cap of 223M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while TRIB trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas TRIB's P/E ratio is -0.18. In terms of profitability, AWH's ROE is +1.62%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, AWH is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for AWH.Check TRIB's competition here
Biodesix, Inc. (NASDAQ: BDSX)
AWH vs BDSX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BDSX has a market cap of 207.9M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BDSX trades at $25.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BDSX's P/E ratio is -8.06. In terms of profitability, AWH's ROE is +1.62%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, AWH is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
AWH vs XGN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, XGN has a market cap of 179.5M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while XGN trades at $7.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas XGN's P/E ratio is -10.77. In terms of profitability, AWH's ROE is +1.62%, compared to XGN's ROE of -1.22%. Regarding short-term risk, AWH is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check XGN's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
AWH vs IMDX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, IMDX has a market cap of 141.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while IMDX trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas IMDX's P/E ratio is -3.68. In terms of profitability, AWH's ROE is +1.62%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, AWH is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
AWH vs GTH Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas GTH's P/E ratio is -1.11. In terms of profitability, AWH's ROE is +1.62%, compared to GTH's ROE of -1.01%. Regarding short-term risk, AWH is less volatile compared to GTH. This indicates lower risk in terms of short-term price fluctuations for AWH.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
AWH vs GENE Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas GENE's P/E ratio is -38.25. In terms of profitability, AWH's ROE is +1.62%, compared to GENE's ROE of -1.85%. Regarding short-term risk, AWH is similarly volatile compared to GENE. This indicates similar risk in terms of short-term price fluctuations for AWH.Check GENE's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
AWH vs SERA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, SERA has a market cap of 76M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while SERA trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas SERA's P/E ratio is -3.06. In terms of profitability, AWH's ROE is +1.62%, compared to SERA's ROE of -0.47%. Regarding short-term risk, AWH is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check SERA's competition here
Atlantic International Corp. (NASDAQ: ATLN)
AWH vs ATLN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ATLN's P/E ratio is -0.68. In terms of profitability, AWH's ROE is +1.62%, compared to ATLN's ROE of +14.94%. Regarding short-term risk, AWH is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ATLN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
AWH vs DRIO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DRIO has a market cap of 52.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DRIO trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DRIO's P/E ratio is -1.22. In terms of profitability, AWH's ROE is +1.62%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, AWH is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DRIO's competition here
Precipio, Inc. (NASDAQ: PRPO)
AWH vs PRPO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PRPO has a market cap of 49.7M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PRPO trades at $27.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PRPO's P/E ratio is -107.12. In terms of profitability, AWH's ROE is +1.62%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, AWH is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PRPO's competition here
MDxHealth S.A. (NASDAQ: MDXH)
AWH vs MDXH Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MDXH has a market cap of 39M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MDXH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MDXH's P/E ratio is -2.00. In terms of profitability, AWH's ROE is +1.62%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, AWH is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MDXH's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
AWH vs QUCY Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, QUCY has a market cap of 32.8M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while QUCY trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas QUCY's P/E ratio is -0.06. In terms of profitability, AWH's ROE is +1.62%, compared to QUCY's ROE of -3.26%. Regarding short-term risk, AWH is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for AWH.Check QUCY's competition here
Akumin Inc. (NASDAQ: AKU)
AWH vs AKU Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas AKU's P/E ratio is -0.13. In terms of profitability, AWH's ROE is +1.62%, compared to AKU's ROE of -5.32%. Regarding short-term risk, AWH is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for AWH.Check AKU's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
AWH vs CEMI Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CEMI's P/E ratio is -0.63. In terms of profitability, AWH's ROE is +1.62%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, AWH is similarly volatile compared to CEMI. This indicates similar risk in terms of short-term price fluctuations for AWH.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
AWH vs ENZ Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ENZ's P/E ratio is -2.24. In terms of profitability, AWH's ROE is +1.62%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, AWH is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
AWH vs PMD Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PMD's P/E ratio is -5.24. In terms of profitability, AWH's ROE is +1.62%, compared to PMD's ROE of -0.32%. Regarding short-term risk, AWH is similarly volatile compared to PMD. This indicates similar risk in terms of short-term price fluctuations for AWH.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
AWH vs ME Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ME's P/E ratio is -0.03. In terms of profitability, AWH's ROE is +1.62%, compared to ME's ROE of -42.03%. Regarding short-term risk, AWH is similarly volatile compared to ME. This indicates similar risk in terms of short-term price fluctuations for AWH.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
AWH vs MYNZ Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, AWH's ROE is +1.62%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, AWH is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MYNZ's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
AWH vs BNGO Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BNGO has a market cap of 14.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BNGO trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BNGO's P/E ratio is -0.28. In terms of profitability, AWH's ROE is +1.62%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, AWH is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BNGO's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
AWH vs ADVB Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ADVB has a market cap of 11.5M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ADVB trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ADVB's P/E ratio is -75.91. In terms of profitability, AWH's ROE is +1.62%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, AWH is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ADVB's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
AWH vs BNR Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BNR has a market cap of 11M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BNR trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BNR's P/E ratio is -12.65. In terms of profitability, AWH's ROE is +1.62%, compared to BNR's ROE of -0.11%. Regarding short-term risk, AWH is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BNR's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
AWH vs CHEK Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CHEK's P/E ratio is -0.43. In terms of profitability, AWH's ROE is +1.62%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, AWH is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
AWH vs CNTG Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CNTG's P/E ratio is -0.23. In terms of profitability, AWH's ROE is +1.62%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, AWH is similarly volatile compared to CNTG. This indicates similar risk in terms of short-term price fluctuations for AWH.Check CNTG's competition here
Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI)
AWH vs MBAI Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MBAI has a market cap of 8.5M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MBAI trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MBAI's P/E ratio is 12.60. In terms of profitability, AWH's ROE is +1.62%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, AWH is less volatile compared to MBAI. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MBAI's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
AWH vs APDN Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas APDN's P/E ratio is -0.10. In terms of profitability, AWH's ROE is +1.62%, compared to APDN's ROE of -7.23%. Regarding short-term risk, AWH is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for AWH.Check APDN's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
AWH vs NDRA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NDRA has a market cap of 5.7M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NDRA trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NDRA's P/E ratio is -0.58. In terms of profitability, AWH's ROE is +1.62%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, AWH is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NDRA's competition here
Invitae Corporation (NYSE: NVTA)
AWH vs NVTA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NVTA's P/E ratio is -0.00. In terms of profitability, AWH's ROE is +1.62%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, AWH is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
AWH vs LMDXW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, AWH's ROE is +1.62%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, AWH is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
AWH vs LMDX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas LMDX's P/E ratio is -0.01. In terms of profitability, AWH's ROE is +1.62%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, AWH is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check LMDX's competition here
DermTech, Inc. (NASDAQ: DMTK)
AWH vs DMTK Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DMTK's P/E ratio is -0.04. In terms of profitability, AWH's ROE is +1.62%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, AWH is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
AWH vs NOTV Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NOTV's P/E ratio is -0.03. In terms of profitability, AWH's ROE is +1.62%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, AWH is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NOTV's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
AWH vs BIAF Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BIAF has a market cap of 2.6M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BIAF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BIAF's P/E ratio is -0.05. In terms of profitability, AWH's ROE is +1.62%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, AWH is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
AWH vs SQL Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas SQL's P/E ratio is -0.40. In terms of profitability, AWH's ROE is +1.62%, compared to SQL's ROE of +38.02%. Regarding short-term risk, AWH is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for AWH.Check SQL's competition here
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
AWH vs INBS Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, INBS has a market cap of 1.8M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while INBS trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas INBS's P/E ratio is -0.32. In terms of profitability, AWH's ROE is +1.62%, compared to INBS's ROE of -1.70%. Regarding short-term risk, AWH is less volatile compared to INBS. This indicates lower risk in terms of short-term price fluctuations for AWH.Check INBS's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
AWH vs HTGM Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas HTGM's P/E ratio is -0.03. In terms of profitability, AWH's ROE is +1.62%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, AWH is similarly volatile compared to HTGM. This indicates similar risk in terms of short-term price fluctuations for AWH.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
AWH vs BIOC Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BIOC's P/E ratio is -0.01. In terms of profitability, AWH's ROE is +1.62%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, AWH is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
AWH vs ISPC Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, ISPC has a market cap of 330.5K. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while ISPC trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas ISPC's P/E ratio is -0.08. In terms of profitability, AWH's ROE is +1.62%, compared to ISPC's ROE of -4.62%. Regarding short-term risk, AWH is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for AWH.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
AWH vs SQLLW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, AWH's ROE is +1.62%, compared to SQLLW's ROE of +38.02%. Regarding short-term risk, AWH is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check SQLLW's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
AWH vs OCDX Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas OCDX's P/E ratio is -42.28. In terms of profitability, AWH's ROE is +1.62%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, AWH is less volatile compared to OCDX. This indicates lower risk in terms of short-term price fluctuations for AWH.Check OCDX's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
AWH vs MEUSW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas MEUSW's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, AWH is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
AWH vs PRXL Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, PRXL has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas PRXL's P/E ratio is 42.97. In terms of profitability, AWH's ROE is +1.62%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, AWH is less volatile compared to PRXL. This indicates lower risk in terms of short-term price fluctuations for AWH.Check PRXL's competition here
Danaher Corporation (NYSE: DHR-PA)
AWH vs DHR-PA Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, AWH's ROE is +1.62%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, AWH is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for AWH.Check DHR-PA's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
AWH vs CHEKZ Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, AWH is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for AWH.Check CHEKZ's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
AWH vs BNGOW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas BNGOW's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, AWH is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check BNGOW's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
AWH vs NDRAW Comparison August 2026
Aspira Women's Health Inc. (NASDAQ: AWH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AWH stands at 2.5M. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, AWH is priced at $0.08 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AWH currently has a P/E ratio of -0.09, whereas NDRAW's P/E ratio is N/A. In terms of profitability, AWH's ROE is +1.62%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, AWH is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for AWH.Check NDRAW's competition here